Skip to main content
SpringerLink
Log in

Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

Porphyria cutanea tarda (PCT) was diagnosed in 27 women aged 23–48 years (mean, 35 years) who had been under oral-hormonal-contraceptive medication for 1–18 years, in 3 women under substitutional estrogen treatment in the menopause, and in 2 men aged 65 and 76 years after estrogen treatment of prostatic carcinoma. In all patients, total urinary porphyrin excretion was elevated, with an average uro-and heptacarboxyporphyrin predominance of 88%, thus proving PCT. On the patients, 84% showed a significant decrease of erythrocyte uroporphyrinogen-decarboxylase (UD; EC 4.1.1.37) activity to ≈50% of control levels suggesting a hereditary predisposition for the development of a chronic hepatic porphyria. Estrogens and alcohol are capable of reducing hepatic UD activity. Women with hereditary red cell UD deficiency may be regarded as predisposed to PCT when under estrogen intake, especially in combination with the potentiating influence of alcohol and chronic liver disease. Normal erythrocyte UD values in patients with additive alcohol consumption may implicate a stronger inhibitory effect for alcohol on UD, suggesting a merely toxic form of chronic hepatic porphyria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson KE, Bradlow HL, Sassa S, Kappas A (1979) Studies in porphyria. VII. Relationship of the 5α-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria. Am J Med 66:644–650

    Google Scholar 

  2. Becker FT (1965) Porphyria cutanea tarda induced by estrogens. Arch Dermatol 92:252–255

    Google Scholar 

  3. Benedetto AV, Kushner JP, Taylor JS (1978) Porphyria cutanea tarda in three generations of a single family. N Engl J Med 298:358–362

    Google Scholar 

  4. de Salamanca RE, Mingo D, Chinarro S, Munoz JJ, Perpiná J (1982) Patterns of porphyrin excretion in female estrogeninduced porphyria cutanea tarda. Arch Dermatol Res 274:179–184.

    Google Scholar 

  5. de Verneuil H, Aitken G, Nordmann Y (1978) Familial and sporadic porphyria cutanea. Two different diseases. Hum Genet 42:145–151

    Google Scholar 

  6. de Verneuil H, Sassa S, Kappas A(1983) Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. J Biol Chem 258:2454–2460

    Google Scholar 

  7. de Verneuil H, Beaumont C, Deybach J-C, Nordmann Y, Sfar Z, Kastally R (1984) Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria. Am J Hum Genet 36:613–622

    Google Scholar 

  8. Doss M (1974) Porphyrins and porphyrin precursors. In: Curtius HC, Roth M (eds) Clinical biochemistry, principles and methods. De Gruyter, Berlin New York, pp 1323–1371

    Google Scholar 

  9. Doss M (1977) Porphyria cutanea tarda durch hormonelle Kontrazeption. Dtsch Med Wochenschr 102:875–877

    Google Scholar 

  10. Doss M (1982) Hepatic porphyrias: pathobiochemical, diagnostic, and therapeutic implications. In: Popper H, Schaffner F (eds) Progress in liver diseases. Grune and Stratton, New York, pp 573–597

    Google Scholar 

  11. Doss M, Look D, Henning H, Nawrocki P, Schmidt A, Dölle W, Korb G, Lüders CJ, Strohmeyer G (1972) Hepatic porphyrins and urinary porphyrins and porphyrin precursors in liver cirrhosis. Klin Wochenschr 50:1025–1032

    Google Scholar 

  12. Doss M, von Tiepermann R, Look D, Nikolowski J, Ryckmanns F, Braun-Falco O (1980) Hereditäre und nichthereditäre Form der chronischen hepatischen Porphyrie: Unterschiedliches Verhalten der Uroporphyrinogen-Decarboxylase in Leber und Erythrozyten. Klin Wochenschr 58:1347–1356

    Google Scholar 

  13. Doss M, von Tiepermann R, Stutz G, Teschke R (1981) Alcohol-induced decrease in uroporphyrinogen decarboxylase activity in rat liver and spleen. Enzyme 26:24–31

    Google Scholar 

  14. Elder GH, Lee GB, Tovey JA (1978) Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Eng J Med 299:274–278

    Google Scholar 

  15. Elder GH, Sheppard DM, de Salamanca RE, Olmos A (1980) Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase. Clin Sci 58:477–484

    Google Scholar 

  16. Elder GH, Sheppard DM, Tovey JA, Urquhart AJ (1983) Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda. Lancet 1:1301–1304

    Google Scholar 

  17. Felscher BF, Norris ME, Shih JC (1978) Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and other forms of porphyria. N Engl J Med 299:1095–1098

    Google Scholar 

  18. Graef V, Golf SW, Tyrell C (1982) Further evidence for the participation of 5β-steroids in the development of a porphyria induced by hexachlorobenzene. Arch Toxicol 50:233–239

    Google Scholar 

  19. Granick S (1966) The induction in vitro of the synthesis of aminolevulinic acid synthase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem 241:1359–1375

    Google Scholar 

  20. Grossmann ME, Bickers DR, Poh-Fitzpatrick MB, DeLeo VA (1979) Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med 67:277–286

    Google Scholar 

  21. Hines JD (1980) Effects of alcohol on inborn errors of metabolism: porphyria cutanea tarda and hemochromatosis. Semin Hematol 17:113–118

    Google Scholar 

  22. Ippen H, Aust D (1972) Über den Einfluß von Steroid-Hormonen auf die experimentelle Porphyrie der Ratte durch Hexachlorbenzol. Klin Wochenschr 50:793–795

    Google Scholar 

  23. Kushner JP, Barbuto AJ, Lee GR (1976) An inherited enzymatic defect in porphyria cutanea tarda. Decreased uroporphyrinogen decarboxylase activity. J Clin Invest 58:1089–1097

    Google Scholar 

  24. McColl KEL, Thompson GG, Moore MR, Goldberg A (1980) Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest 10:107–112

    Google Scholar 

  25. Malina L, Chlumsky J (1975) Oestrogen induced familial porphyria cutanea tarda. Br J Dermatol 92:707–709

    Google Scholar 

  26. Pimstone NR (1982) Porphyria cutanea tarda. Semin Liver Dis 2:132–142

    Google Scholar 

  27. Roenigk HH, Gottlob ME (1970) Estrogen induced porphyria cutanea tarda. Report of three cases. Arch Dermatol 102:260–266

    Google Scholar 

  28. Simon N, Berko G, Dobozy A (1973) Der Einfluß der Sexualhormone auf den Porphyrinstoffwechsel in Modellversuchen. Dermatol Monatsschr 159:868–871

    Google Scholar 

  29. Smith AG, Francis JE (1981) Increased inhibition of hepatic uroporphyrinogen decarboxylase by hexachlorobenzene in male rats given the oestrogenic drugs diethylstilboestrol and chlorotrianisene. Biochem Pharmacol 30:1849–1853

    Google Scholar 

  30. Taylor JS, Roenigk HH Jr (1976) Estrogen induced porphyria cutanea tarda symptomatica. In: Doss M (ed) Porphyrins in human diseases. Karger, Basel, pp 328–335

    Google Scholar 

  31. von Tieperman R, Doss M (1978) Üroporphyrinogen-Decarboxylase in Erythrozyten: Untersuchungen zum primären genetischen Enzymdefekt bei chronischer hepatischer Porphyrie. J Clin Chem Clin Biochem 16:513–517

    Google Scholar 

  32. von Tieperman R, Topi G, Gandolfo LD'A, Doss M (1978) Uroporphyrinogen decarboxylase defect in erythrocytes in hereditary chronic hepatic porphyria. J Clin Biochem 16:52–54

    Google Scholar 

  33. von Tiepermann R, Koss G, Doss M (1980) Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria. Hoppe-Seylerz Z Physiol Chem 361:1217–1222

    Google Scholar 

  34. Zaumseil R-P, Fiedler H (1983) Mögliche Nebenwirkung der hormonalen Kontrazeption: Porphyria cutanea tarba. Zentralbl Gynakol 105:527–531

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Biochemistry of the Faculty of Medicine at the Philipp University, Deutschhausstrasse 17 1/2, D-3550, Marburg, Federal Republic of Germany

    F. Sixel-Dietrich & M. Doss

Authors
  1. F. Sixel-Dietrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Doss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sixel-Dietrich, F., Doss, M. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. Arch Dermatol Res 278, 13–16 (1985). https://doi.org/10.1007/BF00412489

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00412489

Key words

Search

Navigation